COMMUNIQUÉS West-GlobeNewswire

Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai
09/05/2019
Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI ® IV in China and a Co-Detailing collaboration in Shanghai Lugano, Switzerland, and Beijing, China, May 9, 2019 : Helsinn Group, a Swiss [...]
BioPorto Announces Q1 2019 Report
09/05/2019
May 9, 2019 Announcement no. 6 Q1 2019 Report Highlights FDA application processes for The NGAL Test™ on schedule In the first quarter of 2019 BioPorto focused intensively on driving our clinical studies and preparation [...]
Nexstim Plc: New shares have been registered
09/05/2019
Company announcement, Helsinki, 9 May 2019 at 9.00 AM Nexstim Plc: New shares have been registered Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( " Nexstim " or " Company " ), the targeted neuromodulation company developing and [...]
Terveystalo Plc: Terveystalo Group Interim report 1 January -31 March 2019
09/05/2019
Growth in all customer groups, Attendo integration on track Terveystalo Plc Interim report 9 May 2019 at 9:00 am EEST This release is a summary of Terveystalo's Interim Report for 1 January – 31 March 2019. The full [...]
Three-month interim report (Q1) 2019
09/05/2019
Strong sales growth in Q1 (unaudited) In Q1, ALK had organic growth of 14% and continued to deliver on its growth strategy, which saw accelerated growth in tablet sales of 52% and further stabilisation of its legacy AIT [...]
ObsEva Reports First Quarter 2019 Financial Results
09/05/2019
2019 Phase 3 Data Readouts on track for nolasiban in IVF and linzagolix in uterine fibroids; MAA submission for nolasiban IVF therapy targeted by year-end GENEVA, Switzerland and BOSTON, MA. (May 9, 2019) – ObsEva SA ( [...]
ObsEva SA Announces Initiation of Phase 3 EDELWEISS 2 and 3 Trials of Linzagolix for Endometriosis Associated Pain in U.S., Canada and Europe
09/05/2019
Geneva, Switzerland and Boston, MA – May 9, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
New Study Demonstrates Safety and Effectiveness of the MiniMed(TM) 640G System Reducing Hypoglycemia Compared with Insulin Pump Therapy Without CGM in Type 1 Diabetes
09/05/2019
DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology . 1 The SMILE study ( S tudy of M [...]
Quorum Health Corporation Selects R1 RCM for End-to-End Revenue Cycle Management Across 26 Hospitals and Outpatient Centers in 14 States
09/05/2019
CHICAGO, May 08, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, announced today that a wholly owned [...]
NextCure Announces Pricing of Initial Public Offering of Common Stock
09/05/2019
BELTSVILLE, Md., May 08, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
Axcella Health Announces Pricing of Initial Public Offering
09/05/2019
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and [...]
Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care
09/05/2019
Xiidra (lifitegrast ophthalmic solution) 5% fits strategically within industry-leading USD 4.6 billion Novartis ophthalmic pharmaceutical portfolio, laying groundwork for front-of-the-eye pipeline products currently in [...]
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
09/05/2019
CHARLESTON, S.C., May 08, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) announced today at its annual and special shareholders’ meeting held on May 8, 2019, that the individuals noted below [...]
IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer
08/05/2019
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Board of Directors appointed [...]
Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results
08/05/2019
Company to present an interim update of data from the MANIFEST clinical trial of CPI-0610 at ASCO on June 3 and at EHA on June 15 Related investor event at ASCO to be held on June 4 CAMBRIDGE, Mass., May 08, 2019 (GLOBE [...]
electroCore to Announce First Quarter 2019 Financial Results on Tuesday, May 14
08/05/2019
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report [...]
MyoKardia to Present at Bank of America Merrill Lynch 2019 Health Care Conference
08/05/2019
SOUTH SAN FRANCISCO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious [...]
Evoke Pharma Reports First Quarter 2019 Financial Results
08/05/2019
Projected cash runway extended to first quarter 2020 SOLANA BEACH, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for [...]
Nephros Reports First Quarter Financial Results
08/05/2019
Revenues up 80% over Q1 2018 Driven by Hospital Footprint Expansion Reiterates 2019 Guidance for Revenue Growth of 50% to 65% SOUTH ORANGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB [...]

Pages